A fault in J&J MedTech’s CEREPAK detachable coils, used in intracranial aneurysm embolisation procedures, has been associated ...
Acquisitions and spinoffs in 2025 surpassed the previous three years, according to a report from Bain & Company.
The FDA has flagged J&J Medtech’s recall of its Cerepak detachable coils as Class I in the wake of one death and four serious ...
From M&A to surgical robotics and user fee negotiations, the medical device industry has a busy year ahead. Check out MedTech ...
Medtech startups struggle with funding as strategic buyers consolidate, preferring fully developed products over early ...
Discover how global tariffs are driving changes in medtech growth strategies, M&A activities, and manufacturing footprints.
Johnson & Johnson MedTech (NYSE:JNJ) today announced 12-month pilot data from a study of its investigational Omnypulse ...
Medtech dealmaking rebounded last year, and, in 2026, M&A players are seeking to “outperform the next-best owner” amid softer valuations for assets. | Bain & Company’s new 2026 global M&A report found ...
Argá Medtech today announced positive findings from a first-in-human study of its Coherent Sine-Burst Electroporation (CSE) system.
While in 2025 med-tech financings averaged $3.3 billion per month, January 2026 saw the sector bring in $1.52 billion across 39 transactions. It was the lowest monthly total since November 2024’s $924 ...
Medtech leaders reveal how VC landscape has shifted from moonshot innovation to quick exits, and share strategies for ...
Aztron Medtech, a privately held orthopedic device company, today announced that more than 100 clinical procedures have now ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results